Irene Paterniti
Messina, 98166, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 155 publications
RETRACTED: Scuderi et al. Efficacy of a Product Containing Xyloglucan and Pea Protein on Intestinal Barrier Function in a Partial Restraint Stress Animal Model. Int. J. Mol. Sci. 2022, 23, 2269.
Journal: International journal of molecular sciences
Published: May 19, 2026
RETRACTED: "Evidence for the Role of Peroxisome Proliferator-Activated Receptor- β/δ in the Development of Spinal Cord Injury".
Journal: The Journal of pharmacology and experimental therapeutics
Published: May 01, 2026
Correction: Filippone et al. Inhibition of LRRK2 Attenuates Depression-Related Symptoms in Mice with Moderate Traumatic Brain Injury. Cells 2023, 12, 1040.
Journal: Cells
Published: April 13, 2026
Nrf2/NOX2 Pathway Dysregulation and Oxidative Stress Biomarkers in Gaucher Disease-Associated Parkinsonism: Insights Into a Potential Therapeutic Target.
Journal: Journal of cellular and molecular medicine
Published: April 02, 2026
Troxerutin Activity Against Oxidative Stress: A Potential Strategy for Corneal Damage Evaluated in a 3D Model of Human Corneal Epithelial Cells.
Journal: Frontiers in bioscience (Landmark edition)
Published: March 13, 2026
Molecular insights into NLRP3 inflammasome and miRNA modulation in oral cancer.
Journal: Frontiers in pharmacology
Published: September 25, 2025
Modulation of Wnt/β-Catenin Pathway by Aesculus hippocastanum Extract Enhances Temozolomide Sensitivity in Glioblastoma Cells.
Journal: Journal of cellular and molecular medicine
Published: September 01, 2025
Inhibition of Enhancer of Zeste Homolog 2 alleviates oxidative stress, inflammation and barrier damage of human corneal epithelial cells.
Journal: Experimental eye research
Published: July 09, 2025
Troxerutin Potentiated Temozolomide Induced Antitumor Effect in 2D and 3D Glioblastoma Models.
Journal: Journal of cellular and molecular medicine
Published: May 23, 2025
GIT 27 modulates TLR4/Src/NOX2 signaling pathway: A potential therapeutic strategy to decrease neuroinflammation, oxidative stress and neuronal cell death in Parkinson's disease.
Journal: Free radical biology & medicine
Published: May 05, 2025
Last Updated: 09/26/2026